<div>
  <ul>
    <li>
      <p>
        Telepsychiatry/teletherapy platforms provider Brightside Health has secured USD 33 million in a series C funding round led by S32 with participation from other new investors Kennedy Lewis, Time BioVentures, and Anne Wojcicki (Redwood Pacific) and existing investors ACME, Mousse Partners, and Triventures. This brings the company's total funding to over USD 114 million.
      </p>
    </li>
    <li>
      <p>
        Brightside Health expects to use the funds to help the company expand its product offerings and market reach.
      </p>
    </li>
    <li>
      <p>
        Along with this, the company has added industry expert Trip Hofer to the board of directors to obtain advice on the go-to-market strategy and execution. He was formerly the CEO of Optum Behavioral Health Solutions.
      </p>
    </li>
    <li>
      <p>
        <b>Analyst QuickTake: </b>
        Prior to this, the company raised 
        <a href="https://sp-edge.com/updates/9427">
          USD 50 million
        </a>
         in a series B funding round in March 2022 led by ACME Capital and Mousse Partners to expand its team from 50 employees to an estimated 175, improve its platform, and increase its user base via partnerships.
      </p>
    </li>
  </ul>
  <p>
  </p>
</div>


<div>
  <p>
    <a href="https://www.businesswire.com/news/home/20240326911675/en/Brightside-Health-Raises-Strategic-Series-C-Welcomes-Trip-Hofer-to-Board-of-Directors">
      Press release
    </a>
  </p>
</div>


Mental Health Tech

ANALYST_QUICK_TAKE

<div>
 <p>Brightside Health, a telepsychiatry and teletherapy platforms provider, recently raised USD 33 million in a series C funding round. The round was led by S32 and included support from new investors Kennedy Lewis, Time BioVentures, and Anne Wojcicki (Redwood Pacific), as well as existing investors ACME, Mousse Partners, and Triventures. This latest funding round brings the company's total funds raised to over USD 114 million.</p>
 <p>The funds secured are planned to be used by Brightside Health for the expansion of its product offerings and market reach.</p>
 <p>Additionally, the company has welcomed industry expert Trip Hofer to the board of directors. Hofer will provide advice on go-to-market strategy and execution, drawing on his experience as the former CEO of Optum Behavioral Health Solutions.</p>
 
</div> <p><b>Analyst QuickTake:<br>
 </b> Prior to this, the company raised <a href="https:<br>
//sp-edge.com/updates/9427"> USD 50 million </a> in a series B funding round in March 2022 led by ACME Capital and Mousse Partners to expand its team from 50 employees to an estimated 175, improve its platform, and increase its user base via partnerships.</p>

All Updates

Brightside Health raises USD 33 million in Series C funding to expand its product offerings and market reach

Brightside health launches virtual suicide treatment offering

Brightside raises USD 50 million in Series B funding